Pancreas Disorder and Islet Transplantation

Stem cell-derived pancreatic islet transplantation is a β-cell replacement therapy which involves transplantation of isolated islets from donor pancreas to receiver, for the treatment of insulin-deficient diabetes. Once they are transplanted, the islets start producing insulin and actively regulate blood glucose levels. It was observed that 70% of patients who received an islet cell transplant no longer needs insulin after one year and may not need it in the future. Some of the benefits of Islet Transplantation are

  • Improved blood glucose levels
  • Less need or no need for insulin injections to manage diabetes
  • Fewer or no episodes of severe hypoglycaemia

Related Conference of Pancreas Disorder and Islet Transplantation

September 09-10, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
September 09-10, 2024

4th European Endocrinology and Diabetes Congress

Paris, France
September 25-26, 2024

5th World Summit on Diabetes Expo

Rome, Italy
October 14-15, 2024

3rd International Summit on Hormonal Disorders

Madrid, Spain
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands

Pancreas Disorder and Islet Transplantation Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in